Goodbye androgen hypothesis, hello saturation model.
Abraham
A
Morgentaler
D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001378:Azasteroids / Q000627:therapeutic use*; D013196:Dihydrotestosterone / Q000097:blood*; D000068538:Dutasteride; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood*
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D001378:Azasteroids; D013196:Dihydrotestosterone; D013739:Testosterone; D000068538:Dutasteride